peginterferon alfa-2a 180 MCG in 1 ML Injection

RxCUI
351270
RxNorm name
peginterferon alfa-2a 180 MCG in 1 ML Injection
Display name
peginterferon alfa-2a 180 MCG in 1 ML Injection
Full name
peginterferon alfa-2a 180 MCG in 1 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103964Pegasyspeginterferon alfa-2a351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PegasysPEGINTERFERON ALFA-2Apharmaand GmbHd9290e5b-6d40-2318-e053-2995a90a99162026-07-07Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351270

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
d9290e5b-6d40-2318-e053-2995a90a9916peginterferon alfa-2a 180 MCG in 1 ML InjectionPSN44These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 200220250811
d9290e5b-6d40-2318-e053-2995a90a9916peginterferon alfa-2a 180 MCG/ML Injectable SolutionSY44These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 200220250811
d9290e5b-6d40-2318-e053-2995a90a99161 ML peginterferon alfa-2a 0.18 MG/ML InjectionSCD44These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 200220250811